BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baxevanis CN, Fortis SP, Ardavanis A, Perez SA. Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design. Cancers (Basel) 2020;12:E2908. [PMID: 33050520 DOI: 10.3390/cancers12102908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther 2021;6:254. [PMID: 34238917 DOI: 10.1038/s41392-021-00648-7] [Reference Citation Analysis]
2 Xu X, Zhou Z, Li H, Fan Y. Towards customized cancer vaccines: a promising filed in personalized cancer medicine. Expert Rev Vaccines 2021;20:545-57. [PMID: 33769185 DOI: 10.1080/14760584.2021.1909479] [Reference Citation Analysis]
3 Lau P, Shen M, Ma F, Chen Y, Zhang J, Su J, Chen X, Liu H. A Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma. J Eur Acad Dermatol Venereol 2021. [PMID: 34077578 DOI: 10.1111/jdv.17437] [Reference Citation Analysis]
4 He X, Zhou S, Dolan M, Shi Y, Wang J, Quinn B, Jahagirdar D, Huang WC, Tsuji M, Pili R, Ito F, Ortega J, Abrams SI, Ebos JML, Lovell JF. Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model. J Immunother Cancer 2021;9:e003101. [PMID: 34862254 DOI: 10.1136/jitc-2021-003101] [Reference Citation Analysis]